Medical Device Network on MSN
Countable Labs raises $26M for PCR technology advancement
Countable Labs claims that its Countable PCR technology is “at least 10 times” more sensitive than conventional PCR.
New COVID-19 restrictions for international travel and other activities are fueling consumer demand for highly accurate polymerase chain reaction, or PCR, tests with rapid turnaround times. Some ...
Dr. Matt Binnicker, an expert in the diagnosis of infectious diseases, reviews scenarios where an at-home antigen test is a good option, and when to seek out a lab-based PCR. The omicron variant is ...
Because of its high accuracy, laboratory-based polymerase chain reaction (PCR) testing is the gold standard for infectious disease diagnostics. However, PCR technology requires highly trained staff ...
New guidelines from the U.S. Centers for Disease Control and Prevention (CDC) withdrawing their request for Emergency Use Authorization for a coronavirus test introduced in February 2020 do not mean ...
Countable Labs raises $26 million. Company shares plans for new products to support clinical testing applications and announces hire of sales leader.
COVID-19 tests are in greater demand than ever, and new data about the Omicron variant can make picking and using different types of tests confusing. Molecular tests for COVID-19, like the "RT-PCR" ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results